Explore more publications!
Equatorial Guinea Business Today
Submit Press Release

Equatorial Guinea Business Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Equatorial Guinea Business Today.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 18, 2025

Astra Bitcoin: Dr. Antoun Toubia Launches a Revolutionary Asset-Backed Ecosystem Built on Ethereum
October 18, 2025

Astra Bitcoin: Dr. Antoun Toubia Launches a Revolutionary Asset-Backed Ecosystem Built on Ethereum

Indeterminate GlobeNewswire
NUTX 3-DAY DEADLINE ALERT: Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
October 18, 2025

NUTX 3-DAY DEADLINE ALERT: Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman

Indeterminate GlobeNewswire
Cearvol präsentiert auf der EUHA 2025 sein komplettes Hörgeräte-Sortiment und stellt sein Flaggschiff Wave mit fortschrittlicher KI- und Touchscreen-Technologie vor
October 18, 2025

Cearvol präsentiert auf der EUHA 2025 sein komplettes Hörgeräte-Sortiment und stellt sein Flaggschiff Wave mit fortschrittlicher KI- und Touchscreen-Technologie vor

Indeterminate GlobeNewswire
VRA Investor News: If You Have Suffered Losses in Vera Bradley, Inc. (NASDAQ: VRA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
October 18, 2025

VRA Investor News: If You Have Suffered Losses in Vera Bradley, Inc. (NASDAQ: VRA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
C3.ai, Inc. (AI) Hit With Securities Class Action After Shares Crash 25% On Large Revenue Miss -- Hagens Berman
October 18, 2025

C3.ai, Inc. (AI) Hit With Securities Class Action After Shares Crash 25% On Large Revenue Miss -- Hagens Berman

Indeterminate GlobeNewswire
DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
October 18, 2025

DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated

Indeterminate GlobeNewswire
FCX Investor News: If You Have Suffered Losses in Freeport-McMoRan Inc. (NYSE: FCX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
October 18, 2025

FCX Investor News: If You Have Suffered Losses in Freeport-McMoRan Inc. (NYSE: FCX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
Reconstruction and Opportunities: The CDFG Consumer White Paper 2024-2025 is Released
October 18, 2025

Reconstruction and Opportunities: The CDFG Consumer White Paper 2024-2025 is Released

Indeterminate GlobeNewswire
Molina Healthcare, Inc. (NYSE:MOH) Investors may be Entitled to Recover Losses – Contact BFA Law before December 2 Court Deadline
October 18, 2025

Molina Healthcare, Inc. (NYSE:MOH) Investors may be Entitled to Recover Losses – Contact BFA Law before December 2 Court Deadline

Indeterminate GlobeNewswire
Jefferies Financial Group Inc. (NYSE:JEF) Investors may be Entitled to Recover Losses – Contact BFA Law about its Securities Fraud Investigation
October 18, 2025

Jefferies Financial Group Inc. (NYSE:JEF) Investors may be Entitled to Recover Losses – Contact BFA Law about its Securities Fraud Investigation

Indeterminate GlobeNewswire
Guess?, Inc. (NYSE: GES) Shareholders are Notified of the Pending Investigation into the Authentic Brands Merger – Contact BFA Law if You Hold Shares
October 18, 2025

Guess?, Inc. (NYSE: GES) Shareholders are Notified of the Pending Investigation into the Authentic Brands Merger – Contact BFA Law if You Hold Shares

Indeterminate GlobeNewswire
Newfoundland and Labrador Victims and Survivors of Alcohol and Drug-Related Crashes Remembered at MADD Canada’s Annual Memorial Monument Ceremony
October 18, 2025

Newfoundland and Labrador Victims and Survivors of Alcohol and Drug-Related Crashes Remembered at MADD Canada’s Annual Memorial Monument Ceremony

Indeterminate GlobeNewswire
La cérémonie annuelle de MADD Canada au monument commémoratif de Terre-Neuve-et-Labrador rend hommage aux victimes et survivants de collisions liées à l’alcool et aux drogues
October 18, 2025

La cérémonie annuelle de MADD Canada au monument commémoratif de Terre-Neuve-et-Labrador rend hommage aux victimes et survivants de collisions liées à l’alcool et aux drogues

Indeterminate GlobeNewswire
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
October 18, 2025

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

Indeterminate GlobeNewswire
Celcuity Presents Updated Data at the 2025 ESMO Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer (“mCRPC”)
October 18, 2025

Celcuity Presents Updated Data at the 2025 ESMO Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer (“mCRPC”)

Indeterminate GlobeNewswire
Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer
October 18, 2025

Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer

Indeterminate GlobeNewswire
Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress
October 18, 2025

Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress

Indeterminate GlobeNewswire
Blazpay’s Phase 2 of Crypto Presale Surges With Over $250,000 Raised as XRP and Bitcoin Consolidate
October 18, 2025

Blazpay’s Phase 2 of Crypto Presale Surges With Over $250,000 Raised as XRP and Bitcoin Consolidate

Indeterminate GlobeNewswire
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer
October 18, 2025

AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer

Indeterminate GlobeNewswire
Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025
October 18, 2025

Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions